Literature DB >> 6690756

Detrusor-external sphincter dyssynergia in men with multiple sclerosis: an ominous urologic condition.

J G Blaivas, G A Barbalias.   

Abstract

A total of 27 men with multiple sclerosis underwent urodynamic evaluation as part of a prospective study of voiding dysfunction. Of 18 patients with detrusor-external sphincter dyssynergia 9 suffered serious urologic complications, including repeated episodes of urosepsis, vesicoureteral reflux and urolithiasis. None of the 9 patients without dyssynergia suffered any urologic complications. Urologic complications were correlated highly to the presence of detrusor-external sphincter dyssynergia and the severity of multiple sclerosis but not to duration of multiple sclerosis, age of the patient or type of dyssynergia. Although no treatment was without complications it appears that either anticholinergics plus intermittent self-catheterization or condom catheter drainage is superior to an indwelling catheter for initial conservative treatment. External sphincterotomy or urinary diversion may be necessary if conservative therapy fails.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6690756     DOI: 10.1016/s0022-5347(17)50216-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  Urologic manifestations of multiple sclerosis: proposed treatment algorithms.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

2.  Clinical management of the neurourological syndrome associated with multiple sclerosis and correlations to grade of the disease.

Authors:  G A Barbalias; E N Liatsikos; C Passakos; D Barbalias; G Sakelaropoulos
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

3.  Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients.

Authors:  P Gallien; J-M Reymann; G Amarenco; B Nicolas; M de Sèze; E Bellissant
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

4.  Urodynamic indices change as a result of transrectal microwave thermotherapy (TMT) in benign prostatic hyperplasia (BPH).

Authors:  E Liatsikos; K Dadinis; G Barbalias
Journal:  Int Urol Nephrol       Date:  1996       Impact factor: 2.370

Review 5.  Evaluation of lower urinary tract symptoms in multiple sclerosis patients: Review of the literature and current guidelines.

Authors:  Shachar Moshe Aharony; Ornella Lam; Jacques Corcos
Journal:  Can Urol Assoc J       Date:  2017 Jan-Feb       Impact factor: 1.862

6.  Disturbances of ano-rectal function in multiple sclerosis.

Authors:  A M Nordenbo; J R Andersen; J T Andersen
Journal:  J Neurol       Date:  1996-06       Impact factor: 4.849

7.  Bladder dysfunction in acute transverse myelitis: magnetic resonance imaging and neurophysiological and urodynamic correlations.

Authors:  J Kalita; S Shah; R Kapoor; U K Misra
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-08       Impact factor: 10.154

8.  Bladder dysfunction in mice with experimental autoimmune encephalomyelitis.

Authors:  Cengiz Z Altuntas; Firouz Daneshgari; Guiming Liu; Adebola Fabiyi; Michael Kavran; Justin M Johnson; M Fatih Gulen; Ritika Jaini; Xiaoxia Li; Tara L Frenkl; Vincent K Tuohy
Journal:  J Neuroimmunol       Date:  2008-10-15       Impact factor: 3.478

Review 9.  Treatment of lower urinary tract dysfunction in patients with multiple sclerosis. Committee of the European Study Group of SUDIMS (Sexual and Urological Disorders in Multiple Sclerosis)

Authors:  C J Fowler; P E van Kerrebroeck; A Nordenbo; H Van Poppel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-11       Impact factor: 10.154

10.  Overactive bladder: pharmacologic treatments in the neurogenic population.

Authors:  Michael J Kennelly; William B Devoe
Journal:  Rev Urol       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.